<DOC>
	<DOCNO>NCT00005054</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness temozolomide treat woman advance breast cancer .</brief_summary>
	<brief_title>Temozolomide Treating Women With Advanced Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess therapeutic activity temozolomide term tumor response , progression free overall survival woman advance breast cancer . II . Assess extent ATase depletion DNA methylation peripheral blood patient undergo regimen investigate relationship parameter tumor response . OUTLINE : Patients receive oral temozolomide every 4 hour total 5 dos . Treatment continue every 28 day minimum 2 course maximum 1 year absence unacceptable toxicity disease progression . Patients follow 30 day , every 2 month thereafter . PROJECTED ACCRUAL : A total 14-30 patient accrue study .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven advanced carcinoma breast document progression first line chemotherapy Measurable disease Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 18 Sex : Female Menopausal status : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Absolute neutrophil count least 1,500/mm3 Platelet count least 100,000/mm3 Hemoglobin least 10 g/dL Hepatic : Bilirubin le 1.5 time upper limit normal ( ULN ) AST great 3 time ULN Alkaline phosphatase less 2 time ULN unless arise bone Renal : Creatinine le 1.5 time ULN Other : Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No clinically significant disease would interfere study evaluation No uncontrolled vomit would preclude administration oral medication HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : At least 4 week since prior biologic therapy recover Chemotherapy : See Disease Characteristics At least 4 week since prior chemotherapy recover Endocrine therapy : Not specify Radiotherapy : Recovered prior radiotherapy Surgery : Recovered prior surgery Other : No concurrent experimental drug</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2001</verification_date>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IIIA breast cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>stage IIIB breast cancer</keyword>
</DOC>